Choice of injectable opioid treatment may help former inmates stay on track
NCT ID NCT06880718
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot trial tests two long-acting injectable buprenorphine medications (Sublocade and Brixadi) in 60 incarcerated individuals with opioid use disorder who are about to be released from prison. Participants either choose their preferred medication or are randomly assigned one. The study tracks how well they stay in treatment, their opioid use, and their satisfaction over six months after release. The goal is to see if giving people a choice improves treatment retention and outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Buprenorphine (extended-release injectable formulations: Sublocade and Brixadi)
What this could lead to
If this trial succeeds, it could show that giving people leaving prison a choice of injectable buprenorphine helps them stay in treatment longer and reduces opioid relapse after release.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to everyone. It compares two similar drugs, so differences may be small, and long-term effects are not yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rhode Island Department of Corrections
RECRUITINGCranston, Rhode Island, 02920, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••